LOODUSMARK OÜ
LOODUSMARK OÜ is a OÜ based in Tartu linn, registry code 11136116, status: active. Main activity: Manufacture of pharmaceutical preparations. According to EMTA, turnover for Q3 2026 was €8 646 with employees.
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 8 646 €above 15% of companiesindustry median 234 187 € · companies in the industry: 12
- Revenue · 2025 19 460 €above 40% of companiesindustry median 48 003 € · companies in the industry: 19
- Net profit margin · 2025 39.5 %above 85% of companiesindustry median 9.8 % · companies in the industry: 15
Taxes and turnover
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 8 646 | 1 755 | — | — |
| Q2 2026 | 14 165 | 3 237 | — | — |
| Q1 2026 | — | — | — | — |
| Q4 2025 | 892 | — | — | — |
| Q3 2025 | 17 098 | 3 171 | — | — |
| Q2 2025 | 1 470 | 368 | — | — |
| Q1 2025 | 12 966 | 4 192 | 832 | — |
| Q4 2024 | 9 200 | 1 581 | — | — |
| Q3 2024 | 12 267 | 2 159 | — | — |
| Q2 2024 | 8 824 | 1 485 | — | — |
| Q1 2024 | 2 706 | 273 | — | — |
| Q4 2023 | 3 908 | 856 | — | — |
| Q3 2023 | 4 094 | 1 608 | 388 | — |
| Q2 2023 | 3 329 | 486 | — | — |
| Q1 2023 | 7 235 | 3 138 | 293 | — |
| Q4 2022 | 5 057 | 789 | — | — |
| Q3 2022 | 3 112 | 366 | — | — |
| Q2 2022 | 2 644 | 360 | — | — |
| Q1 2022 | 6 077 | 374 | — | — |
Financials by year
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 19 460 | 7 677 | 0 | 42 592 | 42 472 | 0 |
| 2024 | 43 723 | 29 210 | 1 338 | 39 022 | 34 795 | 0 |
| 2023 | 16 432 | 4 195 | 0 | 13 137 | 10 957 | 0 |
| 2022 | 19 625 | 5 644 | 0 | 13 837 | 11 150 | 0 |
| 2021 | 18 798 | 8 080 | 0 | 13 700 | 13 585 | 0 |
| 2020 | 21 677 | 4 193 | 0 | 8 404 | 7 005 | 0 |
| 2019 | 23 464 | 7 125 | 0 | 12 375 | 11 368 | 0 |
| 2018 | — | — | — | — | — | 0 |
| 2017 | — | — | — | — | — | 0 |
| 2016 | — | — | — | — | — | 0 |
| 2015 | — | — | — | — | — | 0 |
| 2014 | — | — | — | — | — | 0 |
| 2013 | — | — | — | — | — | 0 |
| 2012 | — | — | — | — | — | 0 |
| 2011 | — | — | — | — | — | 0 |
| 2010 | — | — | — | — | — | 0 |
| 2009 | — | — | — | — | — | 0 |
| 2008 | — | — | — | — | — | 0 |
| 2007 | — | — | — | — | — | 0 |
| 2006 | — | — | — | — | — | 0 |
| 2005 | — | — | — | — | — | 0 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 23 Jun 2026 | Company’s own | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 18 Jun 2025 | Company’s own | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 7 Jul 2024 | Company’s own | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 9 Aug 2023 | Company’s own | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 26 Jun 2022 | Company’s own | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 18 Jul 2021 | Company’s own | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 27 Jul 2020 | Company’s own | e-Äriregister |
Board
- Hans OrruBoard member · since 3 Jun 2005
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
Beneficial owners
Founders and other persons
Related companies
Activities (EMTAK)
- 21201Manufacture of pharmaceutical preparations Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 20029087 / M2 7 Jul 2024 |
Warning of deletion from the register: annual report not filed | 10 Oct 2024 | Deficiencies eliminated 8 Jul 2024 |
|
| Ä 20029087 / 8 1 Sep 2023 |
Amendment entry | In force 1 Sep 2023 |
||
| Ä 20029087 / 7 18 Jan 2018 |
Amendment entry | In force 18 Jan 2018 |
||
| Ä 20029087 / 6 6 Dec 2017 |
Amendment entry | In force 6 Dec 2017 |
||
| Ä 20029087 / 5 4 Dec 2017 |
Amendment entry | In force 4 Dec 2017 |
||
| Ä 20029087 / 4 20 May 2016 |
Amendment under Commercial Code § 525 (2) | In force 20 May 2016 |
||
| Ä 20029087 / 3 10 Jul 2012 |
Amendment entry | In force 10 Jul 2012 |
||
| Ä 20029087 / M1 1 Mar 2012 |
Warning of deletion from the register: annual report not filed | 30 Aug 2012 | Deficiencies eliminated 1 Mar 2012 |
|
| Ä 29087 / 2 17 Jun 2009 |
Deletion of activities from the registry card | In force 17 Jun 2009 |
||
| Ä 29087 3 Jun 2005 |
First entry | In force |
Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data